Additionally highly expressed PVT-1 was also associated with aggressive stages and bad prognosis in NSCLC, so it could be a crucial target in the therapeutic interventions of NSCLC (Wan et al. 2016a, b). Here, PVT1 is linked to non-small cell lung carcinoma.